ADAG
Adagene Inc - ADR

209
Mkt Cap
$85.31M
Volume
72,974.00
52W High
$3.16
52W Low
$1.30
PE Ratio
-2.81
ADAG Fundamentals
Price
$1.76
Prev Close
$1.81
Open
$1.84
50D MA
$1.89
Beta
0.11
Avg. Volume
75,182.00
EPS (Annual)
-$0.7426
P/B
2.25
Rev/Employee
$748.23
Loading...
Loading...
News
all
press releases
Adagene Inc. Sponsored ADR (NASDAQ:ADAG) Receives Average Recommendation of "Moderate Buy" from Brokerages
Adagene Inc. Sponsored ADR (NASDAQ:ADAG - Get Free Report) has earned a consensus rating of "Moderate Buy" from the six ratings firms that are covering the firm, MarketBeat reports. One research...
MarketBeat·4d ago
News Placeholder
More News
News Placeholder
Adagene (NASDAQ:ADAG) Upgraded to Strong-Buy at Lifesci Capital
Lifesci Capital raised shares of Adagene to a "strong-buy" rating in a research report on Friday...
MarketBeat·4d ago
News Placeholder
Adagene (NASDAQ:ADAG) Trading 4.1% Higher - Time to Buy?
Adagene (NASDAQ:ADAG) Shares Up 4.1% - Here's What Happened...
MarketBeat·8d ago
News Placeholder
All You Need to Know About Adagene (ADAG) Rating Upgrade to Buy
Adagene (ADAG) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Zacks·2mo ago
News Placeholder
Are Medical Stocks Lagging Adagene (ADAG) This Year?
Here is how Adagene Inc. Sponsored ADR (ADAG) and Bayer Aktiengesellschaft (BAYRY) have performed compared to their sector so far this year.
Zacks·2mo ago
News Placeholder
Is Adagene (ADAG) Stock Outpacing Its Medical Peers This Year?
Here is how Adagene Inc. Sponsored ADR (ADAG) and ANI Pharmaceuticals (ANIP) have performed compared to their sector so far this year.
Zacks·2mo ago
News Placeholder
Is Adagene (ADAG) Outperforming Other Medical Stocks This Year?
Here is how Adagene Inc. Sponsored ADR (ADAG) and CorMedix (CRMD) have performed compared to their sector so far this year.
Zacks·3mo ago
News Placeholder
Adagene Receives FDA Guidance On Future Clinical Development Of Experimental Cancer Drug: Retail Turns Optimistic
Neither the mid-stage nor the late-stage trial of Adagene’s drug needs an arm studying the drug as a monotherapy without Merck’s Keytruda, the company said.
Stocktwits·4mo ago
News Placeholder
Is McKesson (MCK) Outperforming Other Medical Stocks This Year?
Zacks·6mo ago
News Placeholder
Adani Group stocks drop after U.S. probe report on alleged Iranian LPG imports
Investing.com -- Shares of Adani Group companies declined on Tuesday following a Wall Street Journal (WSJ) report that U.S. authorities are investigating whether the conglomerate imported Iranian liquefied petroleum gas (LPG) through its Mundra port in Gujarat, potentially violating U.S. sanctions.
investing.com·6mo ago

Latest ADAG News

View

Advertisement|Remove ads.

Advertisement|Remove ads.